Log In
Print this Print this

CPG 52364

  Manage Alerts
Collapse Summary General Information
Company Pfizer Inc.
DescriptionToll-like receptors (TLRs) 7, 8 and 9 antagonist
Molecular Target Toll-like receptor 7 (TLR7) ; Toll-like receptor 8 (TLR8)
Mechanism of ActionToll-like receptor 9 (TLR9) inhibitor; Toll-like receptor 7 (TLR7) inhibitor
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationLupus
Indication DetailsTreat systemic lupus erythematosus (SLE)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today